Please try another search
Name | Net % | Long % | Short % |
---|---|---|---|
Cash | 8.780 | 8.780 | 0.000 |
Stocks | 91.850 | 91.850 | 0.000 |
Ratios | Value | Category Average |
---|---|---|
P/E Ratio | 28.264 | 23.153 |
Price to Book | 3.907 | 2.997 |
Price to Sales | 4.993 | 3.427 |
Price to Cash Flow | 19.543 | 14.779 |
Dividend Yield | 0.960 | 1.816 |
5 Years Earnings Growth | 15.810 | 19.923 |
Name | Net % | Category Average |
---|---|---|
Healthcare | 97.320 | 97.143 |
Consumer Defensive | 2.250 | 0.802 |
Technology | 0.430 | 0.618 |
Number of long holdings: 56
Number of short holdings: 1
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Jiangsu Hengrui | CNE0000014W7 | 9.89 | 46.16 | -0.04% | |
Nhwa Pharma A | CNE100000CG8 | 8.37 | 25.01 | -0.28% | |
Kelun Pharm A | CNE100000PW7 | 8.00 | 33.87 | +3.17% | |
Salubris Pharm A | CNE100000FW8 | 6.03 | 31.90 | +0.25% | |
Xizang Haisco Pharmaceutical A | CNE100001BC7 | 4.49 | 30.34 | +1.40% | |
SonoScape Medical | CNE100002P91 | 4.08 | 41.38 | -0.19% | |
Shanghai MicroPort EP Medtech | CNE100005PG9 | 4.06 | 25.52 | +0.08% | |
Mabwell Shanghai Bioscience | CNE100005RD2 | 3.98 | 35.37 | -0.67% | |
RemeGen | CNE100005B03 | 3.50 | 55.55 | -1.70% | |
New Industries | CNE100003T39 | 3.09 | 70.66 | -2.24% |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
001668 | 20.35B | 11.70 | 5.01 | - | ||
China Universal Consumer Industries | 13.91B | 2.53 | -12.90 | 16.72 | ||
China Universal Selective Mixed Sec | 9.46B | 7.23 | -13.95 | 12.08 | ||
China Universal Blue Chip Equity Fu | 4.62B | 0.20 | -14.32 | 12.30 | ||
China Universal CSI 300 Dynamic Str | 4.21B | 5.34 | -1.71 | 9.92 |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review